Snyder, Robert W., M.d., Ph.d., P.c.
Clinical trials sponsored by Snyder, Robert W., M.d., Ph.d., P.c., explained in plain language.
-
Parkinson's drug shows promise for blinding eye disease
Disease control CompletedThis study tested a drug called carbidopa-levodopa, normally used for Parkinson's disease, in 20 people with wet age-related macular degeneration (AMD). The goal was to see if the drug is safe and can improve vision and reduce fluid buildup in the retina. Participants had not rec…
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated May 26, 2026 11:05 UTC
-
Parkinson's drug shows promise to cut eye injections for wet AMD
Disease control CompletedThis study tested whether a drug used for Parkinson's disease (carbidopa-levodopa) could help people with wet age-related macular degeneration (AMD). The drug may protect the retina and reduce the need for frequent eye injections. 35 participants who were already receiving standa…
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Parkinson's drug shows promise for eye disease in extension trial
Disease control CompletedThis study tested a drug called carbidopa-levodopa, normally used for Parkinson's disease, in people with wet age-related macular degeneration (AMD). It was a 9-month extension for 35 participants who had already completed an earlier study. The goal was to see if the drug could i…
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC